The Vall d'Hebron Institute of Oncology (VHIO) in Barcelona is looking for a PhD candidate to join the Cell Engineering and Hematologic Immunotherapy Group.
¿Tiene lo que se necesita para triunfar? La siguiente información debe ser leída atentamente por todos los candidatos.
This fully funded position will last 3 years under the CAIMI Synergy Grant.

The candidate will focus on CAR T-cell therapies and cellular immunotherapy research with opportunities to work with advanced technologies like CRISPR and flow cytometry. xhfqzwm
The role offers flexible working hours, extensive training, and numerous benefits.